Of all the kidney stones, those comprising calcium oxalate are by far the most common. Supersaturation of urine with calcium and/or oxalate drives crystallization, and normal host microbiome plays a role in degrading oxalate and reducing urine oxalate supersaturation. However, the totality of microbiome activity and the longitudinal effects of microbiome status on hyperoxaluric conditions have not been defined. Here we take advantage of the ability to "conventionalize" the germ-free mice to examine how microbiome status affects experimental hyperoxaluria and renal calcinosis.
INTRODUCTION AND OBJECTIVES:
Of all the kidney stones, those comprising calcium oxalate are by far the most common. Supersaturation of urine with calcium and/or oxalate drives crystallization, and normal host microbiome plays a role in degrading oxalate and reducing urine oxalate supersaturation. However, the totality of microbiome activity and the longitudinal effects of microbiome status on hyperoxaluric conditions have not been defined. Here we take advantage of the ability to "conventionalize" the germ-free mice to examine how microbiome status affects experimental hyperoxaluria and renal calcinosis.
METHODS: 129/SvEv strain mice (both genders; 7-9 weeks old) born and raised in a germ-free facility and free of fecal microbe as evidenced by negative PCR of 16S rRNA gene were "conventionalized" via transfer to a conventional, germ-containing facility. Strain-and agematched wild-type (WT) mice born and raised in the conventional facility served as controls. Each group was randomized into 2 subgroups, one receiving 5% (w/v) hydroxy-L-proline (HLP) in the drinking water and another receiving regular drinking water. Mice were sacrificed after 30 and 60 days of HLP treatment; renal calcium oxalate crystals were visualized by von Kossa staining; urine oxalate levels determined by a Sigma assay kit; and total fecal microbiome quantified by Realtime PCR of V4 region of 16S rRNA gene.
RESULTS: Conventionalized germ-free (C-GF) mice were highly prone to renal calcinosis, with 100% of the male and 17% of the female forming calcium crystals primarily in the papillae by day 30. The frequency and severity worsened by day 60 with 100% of the female bearing crystals. Furthermore, at day 60, 100% of C-GF male and 30% of the C-GF female exhibited renal pelvic stones. In stark contrast, no crystal or stone was observed in C-GF mice fed with regular water, or in WT mice fed with 5% HLP. The crystal and stone forming status strongly paralleled urine oxalate, as the oxalate levels were significantly higher in C-GF mice than in WT mice. All these differences occurred despite the fact that the C-GF mice recovered nearly 50% of total fecal microbiome during the 60 day period, compared to the WT mice.
CONCLUSIONS: These results are the first demonstration that the lack of host microbiome per se does not cause spontaneous intrarenal calcinosis, but it renders the host highly susceptible to this condition under hyperoxaluria. Our results also suggest that the initial deficiency of microbiome is difficult to restore naturally, a situation that may shed light on the reduction of microbiome after antibiotic treatment. METHODS: ChIP assay and luciferase assay demonstrated that VDR suppressed Slc26a6 expression via directly regulating miR125b. Crystals deposition in mouse kidneys were examined by 3D microCT, polarized light optical microphotography and pizzolato staining.High performance liquid chromatography was used to measure oxalate levels in intracellular and extracellular.
RESULTS: Here, we showed that VitD3 mediated intestinal oxalate secretion and CaOx stone formation via a VDR-miR-125b-Slc26a6-based pathway in vivo and in vitro. First, we demonstrated that VitD3 regulated intestinal oxalate secretion and promoted glyoxylate-induced CaOx crystals formation in a VDR-dependent manner. Using miRNA microarray analysis, we found that miR-125b was significantly induced by 1,25-(OH)2D3 in Caco-2 cells. Chromatin immunoprecipitation assays demonstrated VDR-positive transcriptional activation of miR-125b. MiR-125b in turn inhibited VDR by targeting its 3'-UTR. Notably, this negative feedback loop was broken by the single nucleotide polymorphisms (SNP) rs55774542 in the interaction between miR-125b and VDR 3'-UTR, which altered susceptibility to kidney stones. Additionally, we found that miR-125b regulated endogenous 1,25-(OH)2D3 levels by directly targeting CYP24A1. Luciferase assays verified that miR125b directly targeted the 3'-UTR of Slc26a6.
CONCLUSIONS: Together, our results defined a novel signaling cascade in VitD3-mediated intestinal oxalate imbalance via regulation of the VDR-miR-125b-Slc26a6 pathway, which promoted CaOx crystals formation.
